Hubertus von Baumbach to become next chairman of Boehringer Ingelheim

After 24 years’ service to Boehringer Ingelheim, Professor Andreas Barner will retire as chairman of the board of managing directors on June 30, 2016, and will move to the Shareholders' Committee of Boehringer Ingelheim, a family-owned German pharma major.

He will be succeeded by Hubertus von Baumbach, who the shareholders have appointed as the new chairman of the board of managing directors. Christian Boehringer, chairman of the Shareholders’ Committee, said that this decision provided a successor who would ensure continuity whilst also looking to the future. "Hubertus von Baumbach knows the corporation and its various divisions and his time on the board of managing directors has prepared him well for the company’s future challenges. Along with colleagues on the board of managing directors, he will continue the drive for change at Boehringer Ingelheim in order to secure the company’s independence in the long term," he said.

Mr von Baumbach completed a banking apprenticeship and the first and second German state legal examinations, before going on to receive an MBA from MIT in Cambridge, USA. He has been a member of the board of managing directors since 2009 and is head of the corporate board division finance. Following periods at Roche in the USA and at BI in Canada, he performed various functions in the finance division at Boehringer Ingelheim in Germany.